DE60140950D1 - Neuer gentherapeutischer wirkstoff zur behandlung g - Google Patents

Neuer gentherapeutischer wirkstoff zur behandlung g

Info

Publication number
DE60140950D1
DE60140950D1 DE60140950T DE60140950T DE60140950D1 DE 60140950 D1 DE60140950 D1 DE 60140950D1 DE 60140950 T DE60140950 T DE 60140950T DE 60140950 T DE60140950 T DE 60140950T DE 60140950 D1 DE60140950 D1 DE 60140950D1
Authority
DE
Germany
Prior art keywords
gene
therapy
gentherapeutic
agent
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60140950T
Other languages
English (en)
Inventor
Jiahui Xia
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of DE60140950D1 publication Critical patent/DE60140950D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4846—Factor VII (3.4.21.21); Factor IX (3.4.21.22); Factor Xa (3.4.21.6); Factor XI (3.4.21.27); Factor XII (3.4.21.38)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE60140950T 2000-08-30 2001-08-29 Neuer gentherapeutischer wirkstoff zur behandlung g Expired - Lifetime DE60140950D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN00113652 2000-08-30
CNB011028300A CN1148228C (zh) 2000-08-30 2001-01-19 治疗血友病b的基因药物及其制备方法
PCT/CN2001/001291 WO2002034296A1 (fr) 2000-08-30 2001-08-29 Nouvel agent de therapie genique permettant de traiter l'hemophilie b et son procede de preparation

Publications (1)

Publication Number Publication Date
DE60140950D1 true DE60140950D1 (de) 2010-02-11

Family

ID=25739400

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60140950T Expired - Lifetime DE60140950D1 (de) 2000-08-30 2001-08-29 Neuer gentherapeutischer wirkstoff zur behandlung g

Country Status (8)

Country Link
US (1) US7361639B2 (de)
EP (1) EP1316319B1 (de)
JP (1) JP2004512313A (de)
CN (1) CN1148228C (de)
AT (1) ATE453401T1 (de)
AU (1) AU2002223402A1 (de)
DE (1) DE60140950D1 (de)
WO (1) WO2002034296A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2000268170A1 (en) * 2000-09-04 2002-03-22 Hunan Royal Biotech A cell line expressing mutant human tissue-type plasminogen activator, constructing strategy and method of expressed protein preparation
CN1880458B (zh) * 2005-06-15 2010-04-28 中国医学科学院基础医学研究所 人β-珠蛋白基因簇的人源染色体打靶载体及其应用
US8980382B2 (en) * 2009-12-02 2015-03-17 Applied Materials, Inc. Oxygen-doping for non-carbon radical-component CVD films
US10612041B2 (en) 2014-03-21 2020-04-07 The Board Of Trustees Of The Leland Stanford Junior University Genome editing without nucleases
GB201420139D0 (en) 2014-11-12 2014-12-24 Ucl Business Plc Factor IX gene therapy
IL280637B1 (en) 2017-05-22 2024-07-01 Baxalta Inc Viral vectors encoding recombinant FIX with increased expression for gene therapy of hemophilia B
US10842885B2 (en) 2018-08-20 2020-11-24 Ucl Business Ltd Factor IX encoding nucleotides

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2162497A1 (en) * 1993-06-10 1994-12-22 Sheila Connelly Adenoviral vectors for treatment of hemophilia
WO2000017375A2 (en) * 1998-09-23 2000-03-30 Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw Method to treat haemophilia by in vivo gene therapy with retroviral vectors

Also Published As

Publication number Publication date
ATE453401T1 (de) 2010-01-15
CN1148228C (zh) 2004-05-05
EP1316319A1 (de) 2003-06-04
EP1316319B1 (de) 2009-12-30
JP2004512313A (ja) 2004-04-22
EP1316319A4 (de) 2008-08-06
AU2002223402A1 (en) 2002-05-06
CN1302664A (zh) 2001-07-11
US7361639B2 (en) 2008-04-22
US20040038919A1 (en) 2004-02-26
WO2002034296A1 (fr) 2002-05-02

Similar Documents

Publication Publication Date Title
HUP0203056A1 (hu) Vakcinakészítmény
DE60035778D1 (de) Rekombinante influenzaviren zur vakzinherstellung und gentherapie
HUP9901254A2 (hu) Nemdendrites szerkezetű gerincet alkotó peptid hordozó
BR9814276A (pt) Antìgenos de superfìcie
ATE389724T1 (de) Menschliche dnase i hyperaktive varianten
BR0211079A (pt) Processos para a modificação genética de células hematopoiéticas progenitoras e empregos das células modificadas
CY1105221T1 (el) Ιατρικη χρηση θυρεοειδομιμητικων ενωσεων για την θepαπευτικη αγωγη της τριχοπτωσης και φαρμακευτικες συνθεσεις
HUP0402259A2 (hu) Vakcinák
GB0109297D0 (en) Vaccine
FR2827605B1 (fr) Nouveaux peptides derives de la proteine g du vrs et leur utilisation dans un vaccin
ES2168361T3 (es) Secuencias de adn para metaloproteasas de la matriz, su preparacion y empleo.
CY1112867T1 (el) Πεπτιδια επιτοπων που προερχονται απο τον υποδοχεα 1 του αγγειακου ενδοθηλιακου αυξητικου παραγοντα και εμβολια περιεχοντας αυτα τα πεπτιδια
ATE285239T1 (de) Dna enthaltende impfstoffen
YU68702A (sh) Novi lhrh-antagonisti, njihova proizvodnja i upotreba kao leka
DE60140950D1 (de) Neuer gentherapeutischer wirkstoff zur behandlung g
DE50010519D1 (de) Pharmazeutische Zusammensetzungen zur Therapie der Herzinsuffizienz
MA27474A1 (fr) Vaccin
ATE366819T1 (de) Genetische immunisierung gegen zervixkarzinom
DE60107888D1 (de) Beta-Interferon zur Behandlung von Immunerkrankungen
DE60134234D1 (de) Nukleinsäurekonstrukte, damit transformierte vaskuläre zellen, pharmezeutische zusammensetzungen und verfahren zur induktion der angiogenese
DK1268522T3 (da) LH-RH-antagonister samt fremstilling deraf og anvendelse deraf som lægemidler
DE60032372D1 (de) Arzneizubereitungen enthaltend paclitaxel eingeschlossen in nanopartikeln von polymerischen mizellen
SE9700244D0 (sv) Novel antibacterial protein
ITMI20030860A1 (it) Metodo per l'inibizione selettiva del gene n-myc
DE60130994D1 (de) Anti-hiv und anti-tumor lysozympeptide sowie fragmente

Legal Events

Date Code Title Description
8364 No opposition during term of opposition